Approval · Notice of Compliance 16882 · 2015
NORVIR: Notice of Compliance 16882
Issued May 8, 2015
A Notice of Compliance is Health Canada’s approval of a drug submission: a new drug, a new use or form, or a change to an approved one. The product itself is in the Drug Product Database, with its current status.
- Notice number
- 16882
- Date
- May 8, 2015
- Company
- AbbVie CorporationSaint-Laurent, Quebec, Canada
- Product type
- Prescription Pharmaceutical
- Submission
- Supplement to a New Drug Submission (SNDS), supplement
- Submission class
- Other
- Reason
- Removal of references to soft elastic capsules from the product monograph
- Therapeutic class
- HIV protease inhibitor
Products in this notice
| Brand | DIN | Status today |
|---|---|---|
| NORVIR | Not yet assigned | — |